Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Auditor change
Appointed director
|
|
Eidos Therapeutics, Inc. (EIDX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/05/2021 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 01/28/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/26/2021 |
SC 13D/A
| Eidos Therapeutics, Inc. reports a 0% stake in BridgeBio Pharma, Inc. |
| 01/26/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/26/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/26/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/26/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 01/26/2021 |
SC 13D/A
| BridgeBio Pharma, Inc. reports a 100% stake in Eidos Therapeutics, Inc. |
| 01/26/2021 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 01/26/2021 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financia...|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Amended and Restated Certificate of Incorporation of Eidos Therapeutics, Inc",
"Amended and Restated Bylaws of Eidos Therapeutics, Inc",
"First Loan Modification Agreement, to the Loan and Security Agreement, by and between Eidos Therapeutics, Inc., as borrower, Silicon Valley Bank, as administrative agent, collateral agent, and lender and Hercules Capital, Inc., as lender" |
|
| 01/26/2021 |
GN
| BridgeBio Pharma, Inc. Announces Completion of Merger with Eidos Therapeutics, Inc. |
| 01/20/2021 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits Interac... |
| 01/19/2021 |
GN
| Stockholders of BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Approve BridgeBio Pharma, Inc. Acquisition of Eidos Therapeutics, Inc. |
| 01/13/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 01/13/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 01/12/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 01/12/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 01/12/2021 |
8-K
| Quarterly results |
| 01/07/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 01/04/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 01/04/2021 |
GN
| EIDOS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of EIDX and Encourages Investors to Contact the Firm |
| 01/04/2021 |
GN
| Leading Independent Proxy Advisory Firm ISS Recommends BridgeBio Pharma and Eidos Therapeutics Stockholders Vote “FOR” Proposed Merger |
| 12/30/2020 |
GN
| SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers – CKH, WDR, NAV, EIDX |
| 12/29/2020 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 12/28/2020 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 12/24/2020 |
GN
| ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers – STND, EIDX, ARA, RESI |
| 12/15/2020 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 12/12/2020 |
GN
| INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate the Following Companies; Shareholders are Encouraged to Contact the Firm – CBMG, MVC, STND, EIDX |
| 12/02/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of MCEP, EIDX, CCR, and TGC Mergers |
| 11/25/2020 |
GN
| Halper Sadeh LLP Continues to Investigate the Following Mergers; Investors are Encouraged to Contact the Firm – STND, EIDX, WTRE, EV |
| 11/20/2020 |
GN
| ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Investors are Encouraged to Contact the Firm – GLIBA, EIDX, EV, PNM |
| 11/19/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of CXO, CEIX, PNM, and EIDX Mergers |
| 11/13/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of IPHI, EIDX, CEIX, and PNM Mergers |
| 11/07/2020 |
GN
| SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers; Investors are Encouraged to Contact the Firm – EIDX, WTRE, ARA, CIT |
|
|
|